当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析 - 现金流量表

普洛药业

(000739)

  

流通市值:147.85亿  总市值:147.90亿
流通股本:11.78亿   总股本:11.79亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金8,862,726,155.215,986,375,397.513,907,277,244.091,996,810,525.1
收到的税费返还484,128,759.81366,708,211.74269,826,885.69131,669,785.05
收到其他与经营活动有关的现金328,214,960.87258,413,664.71165,927,548.4553,063,936.21
经营活动现金流入的平衡项目0000
经营活动现金流入小计9,675,069,875.896,611,497,273.964,343,031,678.232,181,544,246.36
购买商品、接受劳务支付的现金6,458,584,615.384,197,997,038.542,529,494,244.931,354,349,445.48
支付给职工以及为职工支付的现金941,813,373.09619,943,029.57448,102,504.03293,175,861.05
支付的各项税费481,246,056.29393,637,579.9294,213,077.16122,671,163.16
支付其他与经营活动有关的现金762,062,757.05551,379,185.09328,848,611.43188,403,702.65
经营活动现金流出的平衡项目0000
经营活动现金流出小计8,643,706,801.815,762,956,833.13,600,658,437.551,958,600,172.34
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,031,363,074.08848,540,440.86742,373,240.68222,944,074.02
二、投资活动产生的现金流量:
收回投资收到的现金52,102,285.5645,273,824.718,014,434.64-
处置固定资产、无形资产和其他长期资产收回的现金净额8,961,893.47113,257.095,100-
处置子公司及其他营业单位收到的现金净额30,399,153.0130,400,00030,400,000-
收到的其他与投资活动有关的现金35,153,034.9825,835,345.4525,011,938.324,897,469.93
投资活动现金流入的平衡项目0000
投资活动现金流入小计126,616,367.02101,622,427.2563,431,472.964,897,469.93
购建固定资产、无形资产和其他长期资产支付的现金630,467,013.51417,045,927.79222,115,526.55191,417,635.8
投资支付的现金130,000,000123,199,95849,999,958-
支付其他与投资活动有关的现金42,947,298.1822,178,252.7920,627,284.898,001,470.3
投资活动现金流出的平衡项目0000
投资活动现金流出小计803,414,311.69562,424,138.58292,742,769.44199,419,106.1
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-676,797,944.67-460,801,711.33-229,311,296.48-194,521,636.17
三、筹资活动产生的现金流量:
吸收投资收到的现金375,000375,000--
其中:子公司吸收少数股东投资收到的现金375,000375,000--
取得借款收到的现金1,061,180,916.671,025,000,000695,000,000480,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,061,555,916.671,025,375,000695,000,000480,000,000
偿还债务支付的现金964,665,668.05950,200,000567,200,000367,800,000
分配股利、利润或偿付利息支付的现金383,021,977.07376,165,012.93364,497,623.78,551,272.54
支付其他与筹资活动有关的现金15,352,107.238,347,247.751,738,419.61776,079.5
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,363,039,752.351,334,712,260.68933,436,043.31377,127,352.04
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-301,483,835.68-309,337,260.68-238,436,043.31102,872,647.96
四、汇率变动对现金及现金等价物的影响27,492,395.9335,150,950.5237,622,206.77-5,124,285.68
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额80,573,689.66113,552,419.37312,248,107.66126,170,800.13
加:期初现金及现金等价物余额2,381,912,072.082,381,912,072.082,381,912,072.082,381,912,072.08
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,462,485,761.742,495,464,491.452,694,160,179.742,508,082,872.21
补充资料:
净利润1,055,306,898.23-601,044,120.54-
资产减值准备106,487,344.7-46,392,871.62-
固定资产和投资性房地产折旧538,031,286.28-268,342,719.27-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧538,031,286.28-268,342,719.27-
无形资产摊销15,026,434.82-5,597,625.54-
长期待摊费用摊销5,926,894.02-2,948,564.03-
处置固定资产、无形资产和其他长期资产的损失-1,328,848.13--6,480.27-
固定资产报废损失7,793,162.14-2,392,513.21-
公允价值变动损失19,228.93-13,486,536.21-
财务费用60,329,518.38--45,784,104.27-
投资损失18,064,111.37-787,930.38-
递延所得税3,643,266.88-15,473,029.89-
其中:递延所得税资产减少22,889,492.3-23,905,035.49-
递延所得税负债增加-19,246,225.42--8,432,005.6-
存货的减少-373,347,043.74--95,383,943.39-
经营性应收项目的减少-571,625,127.25--352,539,541.12-
经营性应付项目的增加130,168,077.8-273,185,253.64-
其他36,867,869.65---
现金的期末余额2,462,485,761.74-2,694,160,179.74-
减:现金的期初余额2,381,912,072.08-2,381,912,072.08-
公告日期2024-03-082023-10-192023-08-152023-04-18
审计意见(境内)标准无保留意见
TOP↑